Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Respir Med. 2016 Dec 18;123:34–41. doi: 10.1016/j.rmed.2016.12.010

Figure 2.

Figure 2

Distribution of sputum inflammatory phenotypes in patients with, or without, detectable virus at exacerbation (n.s.). Paucigranulocytic (< 3% eosinophils & < 61% neutrophils), eosinophilic (≥ 3% eosinophils & < 61% neutrophils), neutrophilic (< 3% eosinophils & ≥ 61% neutrophils), mixed granulocytic (≥ 3% eosinophils & ≥ 61% neutrophils).